Search Your Trial
View Clinical Trials
- D001458
- D001775
- D004786
- D009360
- D009863
- D010612
- D011247
- D011471
- D012039
- D014408
- D017202
- D020521
- D035683
- D059350
- D064129
- D3 Dopamine Receptor
- D842-related Mutant GIST
- Dabigatran
- Daboia Siamensis Envenoming
- Dachengqi Decoction
- Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain Metastases
- Dacryoadenitis
- Dacryocystitis
- Dacryocystitis; Chronic
- Dacryocystocele
- Dacryocystorhinostomy
- Dacryostenosis
- Dactinomycin Adverse Reaction
- Daibetic Foot
- Daily Activities
- Daily Activity
- Daily Life
- Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed
- Daily Room Disinfection
- Daily Sedative Interruption
- Daily Self-weighing
- Daily Spontaeous Breathing Trials
- Daily Temperature-taking
- Dairy Intolerance
- Dairy Products
- DALK Corneal Transplant
- Dalteparin
- Damage-associated Molecular Patterns
- Damage Control
- Damage Control for Perforated Diverticulitis
- Damage Control Surgery
- Damaged Mitral Valve
- Damaged Vestibular System
- Damage in the Anterior Spinal Artery (ASA)
- Damage Muscle